Skip to main content

Table 3 Association with stunted growth in height of long-term abnormal DNA methylation within steroidogenic genes in former PICU patients

From: Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time

Gene

CpG site

Gene section a,b

Percentage of significant iterations c

Median (IQR) P-value d

Direction of association e

CYP11A1

cg23808031

Promoter/ 1stExon

100

2.8E-26 (1.8E-26–3.7E-26)

Harm

POR

cg10738873

5'UTR

100

2.2E-11 (1.7E-11–2.9E-11)

Harm

 

cg17115737

5'UTR

100

6.3E-13 (5.0E-13–8.1E-13)

Harm

 

cg27372063

Body

100

1.2E-24 (8.4E-25–1.5E-24)

Harm

CYB5A

cg18274065

Promoter

100

4.6E-29 (3.5E-29–6.4E-29)

Harm

HSD17B1

cg02363277

Body

100

1.7E-10 (1.4E-10–2.0E-10)

Harm

HSD17B2

cg09894383

Promoter

100

8.6E-40 (5.2E-40–1.2E-39)

Harm

 

cg11515282

Promoter

100

8.3E-87 (4.7E-87–1.2E-86)

Harm

 

cg20373326

Promoter

100

1.9E-75 (1.2E-75–3.0E-75)

Harm

 

cg19807685

5'UTR/ 1stExon

100

1.5E-37 (1.0E-37–2.0E-37)

Harm

 

cg26315602

1stExon

100

8.1E-28 (5.6E-28–1.3E-27)

Harm

 

cg00365986

Body

100

6.4E-32 (4.3E-32–9.6E-32)

Harm

 

cg05315365

Body

100

2.6E-80 (1.6E-80–5.0E-80)

Harm

 

cg13740036

Body

100

2.5E-80 (1.6E-80–4.5E-80)

Harm

HSD17B3

cg18014207

Body

100

1.3E-25 (9.3E-26–1.7E-25)

Harm

HSD17B6

cg21922731

5'UTR/ 1stExon

100

8.7E-07 (6.6E-07–1.0E-06)

Harm

HSD17B10

cg26323797

Promoter

100

0.014 (0.013–0.016)

Harm

HSD17B12

cg14262884

Body

100

3.0E-20 (2.1E-20–4.2E-20)

Harm

 

cg21077321

Body

100

7.3E-27 (5.6E-27–1.0E-26)

Harm

CYP19A1

cg12009872

Body

100

4.5E-14 (3.3E-14–6.1E-14)

Harm

 

cg14424631

Body

100

8.9E-07 (7.2E-07–1.0E-06)

Harm

CYP21A2

cg11675917

Promoter

100

5.9E-09 (4.9E-09–6.8E-09)

Harm

CYP11B2

cg14389499

Promoter

100

4.7E-10 (3.8E-10–6.0E-10)

Harm

  1. This table summarises the results of the multivariable linear regression analyses assessing associations between abnormal DNA methylation within genes involved in steroidogenesis 2 years after critical illness and height at 4-year follow-up, adjusted for baseline risk factors and technical variation
  2. UTR untranslated region
  3. aA CpG site can be located within multiple splice variants and thus can be situated within multiple gene sections
  4. bPromoter is defined as 0 to 1500 base pairs upstream of the transcription start site
  5. cPercentage of the 100 iterations for which the Fisher P-values across the 10 test folds is significant (P < 0.05)
  6. dMedian and interquartile range of the Fisher P-values across the 10 test folds obtained for the 100 iterations
  7. eThe label “Harm” for robust associations (significant in at least 50% of the iterations) indicates that the observed abnormal DNA methylation correlates with a shorter height (based on the mean coefficient from the multivariable models)